← Browse by Condition
Medical Condition

next generation sequencing

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06895733 Phase 1, Phase 2
Recruiting

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

Enrollment
65 pts
Location
China
Sponsor
Tianjin Medical University Sec...
View Trial →